Predicting treatment failure in severe sepsis and septic shock: looking for the Holy Grail
- PMID: 24004571
- PMCID: PMC4057107
- DOI: 10.1186/cc12877
Predicting treatment failure in severe sepsis and septic shock: looking for the Holy Grail
Abstract
Procalcitonin has been proposed as a specific biomarker of bacterial infections and has been related to the severity of sepsis. The prognostic ability of the initial concentrations of procalcitonin in sepsis is controversial. Some studies find higher initial concentrations in non-survivors but others find no differences. Prognostic assessment based on follow-up of procalcitonin levels may be better than evaluation of the initial levels of procalcitonin. The persistence of elevated procalcitonin levels is indicative of poor prognosis and is associated with mortality. Procalcitonin kinetics could be a tool for assessing the evolution of severe sepsis and sepsis shock. Procalcitonin should find its place as a biomarker for predicting treatment failure of severe sepsis and septic shock.
Comment on
-
Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients.Crit Care. 2013 Jun 20;17(3):R115. doi: 10.1186/cc12787. Crit Care. 2013. PMID: 23787145 Free PMC article.
References
-
- Lisboa T, Selligman R, Diaz E, Rodriguez A, Teixeira PJ, Rello J. C-reactive protein correlates with bacterial load and appropiate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med. 2008;17:166–171. doi: 10.1097/01.CCM.0000297886.32564.CF. - DOI - PubMed
-
- Harbarth S, Holechova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J. Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001;17:396–402. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
